Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 10 of 57 for:    Romidepsin | Phase 2

FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00085527
Recruitment Status : Withdrawn
First Posted : June 11, 2004
Last Update Posted : September 5, 2013
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Chicago

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : September 2005
  Actual Study Completion Date : September 2005